University’s Alzheimer’s Treatment Gets Clinical Trial Without Industry Partner

University’s Alzheimer’s Treatment Gets Clinical Trial Without Industry Partner
The Vanderbilt University Medical Center has passed a key hurdle in its quest to develop a treatment for Alzheimer’s disease with the announcement that the U.S. Food and Drug Administration (FDA) has approved a Phase 1 clinical trial of the therapy. The development marks one of the few times that a university has taken a treatment from discovery to

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Linda Grishman says:

    I hope this comes sooner rather than later. I am in the early stages of this perilous disease. I am second maternal generation suffering from early stages. Sadly it is worsening. I haven been on Aricept 10mg for years. Still, you can deduce that I am still quite cognizant. It’s my short term memory that plagues me even with my daily reminderss and app alarms. I am wondering if Mementine may be more beneficial. I do hope to receive a response from you. Thank you, Linda Grishman age 67. Burlington, VT

Leave a Comment

Your email address will not be published. Required fields are marked *